Bharat Edition

Bharatstox

MarketsScreenerAnnouncementsResultsStocksMarket map
← All stocks

Zota Health Care Ltd.

NSE: ZOTA · Healthcare

Sector

Healthcare

Size band

Small cap

Market cap

3,955cr

P/E

162

ROE

3.9%

Dividend yield

0.1%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin−7.0%
peer 21.0%
Revenue growth67.3%
peer 16.1%
Zota Health Care Ltd.peer median

Peer set

Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener
CompanyOperating marginRevenue growth
Sun Pharmaceutical Industries Ltd.29.0%10.5%
Divi's Laboratories Ltd.41.0%27.8%
Torrent Pharmaceuticals Ltd.34.0%54.8%
Lupin Ltd.30.0%32.1%
Dr. Reddy's Laboratories Ltd.11.0%−5.5%
Cipla Ltd.17.0%2.3%
Zydus Lifesciences Ltd.24.0%22.0%
Mankind Pharma Ltd.26.0%12.9%
Aurobindo Pharma Ltd.21.0%16.3%
Torrent Power Ltd.19.0%2.8%
Alkem Laboratories Ltd.20.0%10.9%
Zota Health Care Ltd.−7.0%67.3%

What management said

6 statements on record

Earnings call · Q1 FY27 · 20 Aug 2026

  • Store additions→600-650 store additions· FY27
    “For the current financial year, our target remains 600-650 store additions.”
  • Store additions→400-450 stores· next three quarters
    “Having already added 200 stores, we plan to add another 400-450 stores over the next three quarters.”
  • Reported EBITDA→EBITDA-positive territory· from next quarter onwards
    “So, from next quarter onwards, we expect to be back to EBITDA-positive territory.”
  • Pre-Ind AS EBITDA→EBITDA positive on a pre-Ind AS basis· around Q4 FY27 or potentially Q1 FY28
    “If we talk about pre-Ind AS profitability, then we expect to become EBITDA positive on a pre-Ind AS basis by around Q4 FY27 or potentially Q1 FY28.”
  • Cash breakeven→cash breakeven· approximately Q1FY28
    “Based on our current trajectory, we expect to achieve cash breakeven by approximately Q1FY28.”
  • Marketing spend→INR 40 - 45 crores· this financial year
    “We foresee close to around INR 40 - 45 crores kind of numbers.”

Taken from management commentary on the company’s earnings call and quoted verbatim. These are statements of intent made by the company, not forecasts by Bharatstox, and nothing here records whether they were met.

No broadcast calls recorded.

We log calls made about a company on business television — Zee Business, CNBC Awaaz and NDTV Profit — as they are stated on air. Nothing is on record for Zota Health Care Ltd..

Shareholding

change across 4 filings
CategoryJun 26Mar 26Dec 25Dec 25Change
Promoters49.449.450.651.6−2.2
Foreign institutions7.98.28.18.0−0.1
Domestic institutions6.86.47.26.1+0.7
Retail & others36.036.034.134.4+1.6

As filed with the exchange for the periods ending Dec 25 to Jun 26.

Filings

latest 25 of 290

The 25 most recent of 290 filings we hold for ZOTA, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.